Companies
RNS
Signals
Macro
Research
Indices
Ticker TV
Events
Commodities
Currencies
Footer menu
Search...
⌘K
Open sidebar
Developer Portal
News
Services
Coiled Therapeutics PLC (COIL) RNS Announcements | Ticker
/
Equities
/
AIMX
/
COIL
/
RNS
Secondary share class.
The ordinary shares trade as
ROQ
(Roquefort Therapeutics PLC). Director, financial and RNS data shown here are for the issuer.
Overview
Share Price
Financials
RNS
Trades
Short Interest
Directors
Holdings
Coiled Therapeutics PLC RNS
/
Equities
/
AIMX
/
COIL
/
RNS
Secondary share class.
The ordinary shares trade as
ROQ
(Roquefort Therapeutics PLC). Director, financial and RNS data shown here are for the issuer.
Overview
Share Price
Financials
RNS
Trades
Short Interest
Directors
Holdings
Coiled Therapeutics PLC RNS
Add to watchlist
Date
Time
Date
Title
Title
(filtered)
24/01/23
07:00:03
24 Jan 2023
MDK Oncology Antibodies Demonstrate In-Vivo Safety
MDK Oncology Antibodies Demonstrate In-Vivo Safety
18/01/23
08:36:18
18 Jan 2023
Holding(s) in Company
Holding(s) in Company
16/01/23
07:00:06
16 Jan 2023
Appointment of Auditor
Appointment of Auditor
09/01/23
07:00:01
9 Jan 2023
Operations Update
Operations Update
05/12/22
08:07:52
5 Dec 2022
Presentation of Midkine Oligonucleotide Program
Presentation of Midkine Oligonucleotide Program
01/12/22
14:00:06
1 Dec 2022
Resignation of Auditor
Resignation of Auditor
25/10/22
07:00:06
25 Oct 2022
Midkine Antibody Program - Festival of Biologics
Midkine Antibody Program - Festival of Biologics
11/10/22
07:00:17
11 Oct 2022
ROQ Presents Study Results at the ESGCT Conference
ROQ Presents Study Results at the ESGCT Conference
28/09/22
07:00:12
28 Sept 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
26/09/22
14:30:08
26 Sept 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
23/09/22
07:00:06
23 Sept 2022
Interim Results to 30 June 2022
Interim Results to 30 June 2022
16/09/22
08:00:04
16 Sept 2022
Investor Presentation
Investor Presentation
16/09/22
07:01:01
16 Sept 2022
Board and Management Appointments
Board and Management Appointments
16/09/22
07:00:04
16 Sept 2022
Acquisition Completion, Admission & Voting Rights
Acquisition Completion, Admission & Voting Rights
15/09/22
12:26:17
15 Sept 2022
Notice of Admission
Notice of Admission
13/09/22
11:08:19
13 Sept 2022
Publication of Prospectus
Publication of Prospectus
11/08/22
07:00:12
11 Aug 2022
Pre-clinical Program & Transaction Update
Pre-clinical Program & Transaction Update
20/07/22
07:00:09
20 Jul 2022
Appointment of Joint Broker
Appointment of Joint Broker
15/07/22
07:00:05
15 Jul 2022
Commencement of Trading on US OTCQB Venture Market
Commencement of Trading on US OTCQB Venture Market
04/07/22
16:57:51
4 Jul 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
30/06/22
16:38:56
30 Jun 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
30/06/22
10:30:05
30 Jun 2022
Result of AGM
Result of AGM
23/06/22
07:00:03
23 Jun 2022
Update on Acquisition of Oncogeni and Placing
Update on Acquisition of Oncogeni and Placing
22/06/22
16:42:01
22 Jun 2022
Issue of Warrants
Issue of Warrants
22/06/22
10:32:34
22 Jun 2022
Investor Presentation
Investor Presentation
22/06/22
09:05:48
22 Jun 2022
Second Price Monitoring Extn
Second Price Monitoring Extn
22/06/22
09:00:38
22 Jun 2022
Price Monitoring Extension
Price Monitoring Extension
22/06/22
07:00:05
22 Jun 2022
Proposed Acquisition of Oncogeni Limited & Placing
Proposed Acquisition of Oncogeni Limited & Placing
13/06/22
07:00:07
13 Jun 2022
Notice of AGM - Correction
Notice of AGM - Correction
07/06/22
07:00:08
7 Jun 2022
Pre-clinical Update
Pre-clinical Update
07/06/22
07:00:08
7 Jun 2022
Notice of AGM
Notice of AGM
11/05/22
07:00:02
11 May 2022
Annual Report & Financial Statements
Annual Report & Financial Statements
20/04/22
07:00:04
20 Apr 2022
Non-Executive Director Appointment
Non-Executive Director Appointment
05/04/22
07:00:05
5 Apr 2022
Board Appointment
Board Appointment
22/03/22
08:08:00
22 Mar 2022
Holding(s) in Company
Holding(s) in Company
21/03/22
09:34:58
21 Mar 2022
Investor Presentation
Investor Presentation
21/03/22
07:00:10
21 Mar 2022
Patent Filed – New Drug Class Targeting Midkine
Patent Filed – New Drug Class Targeting Midkine
08/03/22
07:54:13
8 Mar 2022
Holding(s) in Company
Holding(s) in Company
14/02/22
07:00:08
14 Feb 2022
Appointment of Strategic & Scientific Advisor
Appointment of Strategic & Scientific Advisor
08/02/22
11:35:22
8 Feb 2022
Holding(s) in Company
Holding(s) in Company
28/01/22
07:00:09
28 Jan 2022
Holding(s) in Company
Holding(s) in Company
19/01/22
12:56:06
19 Jan 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
19/01/22
08:39:56
19 Jan 2022
Holding(s) in Company
Holding(s) in Company
18/01/22
14:00:32
18 Jan 2022
Price Monitoring Extension
Price Monitoring Extension
18/01/22
11:51:52
18 Jan 2022
Holding(s) in Company
Holding(s) in Company
17/01/22
07:00:08
17 Jan 2022
Holding(s) in Company
Holding(s) in Company
17/01/22
07:00:07
17 Jan 2022
Pre-clinical Update
Pre-clinical Update
10/01/22
08:00:08
10 Jan 2022
Publication of New Research
Publication of New Research
31/12/21
07:00:04
31 Dec 2021
Change of Company Name
Change of Company Name
22/12/21
07:00:07
22 Dec 2021
Holding(s) in Company
Holding(s) in Company
Showing 101–150 of 173 announcements
Previous
1
2
3
4
Next
Date
Time
Date
Title
Title
(filtered)
24/01/23
07:00:03
24 Jan 2023
MDK Oncology Antibodies Demonstrate In-Vivo Safety
MDK Oncology Antibodies Demonstrate In-Vivo Safety
18/01/23
08:36:18
18 Jan 2023
Holding(s) in Company
Holding(s) in Company
16/01/23
07:00:06
16 Jan 2023
Appointment of Auditor
Appointment of Auditor
09/01/23
07:00:01
9 Jan 2023
Operations Update
Operations Update
05/12/22
08:07:52
5 Dec 2022
Presentation of Midkine Oligonucleotide Program
Presentation of Midkine Oligonucleotide Program
01/12/22
14:00:06
1 Dec 2022
Resignation of Auditor
Resignation of Auditor
25/10/22
07:00:06
25 Oct 2022
Midkine Antibody Program - Festival of Biologics
Midkine Antibody Program - Festival of Biologics
11/10/22
07:00:17
11 Oct 2022
ROQ Presents Study Results at the ESGCT Conference
ROQ Presents Study Results at the ESGCT Conference
28/09/22
07:00:12
28 Sept 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
26/09/22
14:30:08
26 Sept 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
23/09/22
07:00:06
23 Sept 2022
Interim Results to 30 June 2022
Interim Results to 30 June 2022
16/09/22
08:00:04
16 Sept 2022
Investor Presentation
Investor Presentation
16/09/22
07:01:01
16 Sept 2022
Board and Management Appointments
Board and Management Appointments
16/09/22
07:00:04
16 Sept 2022
Acquisition Completion, Admission & Voting Rights
Acquisition Completion, Admission & Voting Rights
15/09/22
12:26:17
15 Sept 2022
Notice of Admission
Notice of Admission
13/09/22
11:08:19
13 Sept 2022
Publication of Prospectus
Publication of Prospectus
11/08/22
07:00:12
11 Aug 2022
Pre-clinical Program & Transaction Update
Pre-clinical Program & Transaction Update
20/07/22
07:00:09
20 Jul 2022
Appointment of Joint Broker
Appointment of Joint Broker
15/07/22
07:00:05
15 Jul 2022
Commencement of Trading on US OTCQB Venture Market
Commencement of Trading on US OTCQB Venture Market
04/07/22
16:57:51
4 Jul 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
30/06/22
16:38:56
30 Jun 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
30/06/22
10:30:05
30 Jun 2022
Result of AGM
Result of AGM
23/06/22
07:00:03
23 Jun 2022
Update on Acquisition of Oncogeni and Placing
Update on Acquisition of Oncogeni and Placing
22/06/22
16:42:01
22 Jun 2022
Issue of Warrants
Issue of Warrants
22/06/22
10:32:34
22 Jun 2022
Investor Presentation
Investor Presentation
22/06/22
09:05:48
22 Jun 2022
Second Price Monitoring Extn
Second Price Monitoring Extn
22/06/22
09:00:38
22 Jun 2022
Price Monitoring Extension
Price Monitoring Extension
22/06/22
07:00:05
22 Jun 2022
Proposed Acquisition of Oncogeni Limited & Placing
Proposed Acquisition of Oncogeni Limited & Placing
13/06/22
07:00:07
13 Jun 2022
Notice of AGM - Correction
Notice of AGM - Correction
07/06/22
07:00:08
7 Jun 2022
Pre-clinical Update
Pre-clinical Update
07/06/22
07:00:08
7 Jun 2022
Notice of AGM
Notice of AGM
11/05/22
07:00:02
11 May 2022
Annual Report & Financial Statements
Annual Report & Financial Statements
20/04/22
07:00:04
20 Apr 2022
Non-Executive Director Appointment
Non-Executive Director Appointment
05/04/22
07:00:05
5 Apr 2022
Board Appointment
Board Appointment
22/03/22
08:08:00
22 Mar 2022
Holding(s) in Company
Holding(s) in Company
21/03/22
09:34:58
21 Mar 2022
Investor Presentation
Investor Presentation
21/03/22
07:00:10
21 Mar 2022
Patent Filed – New Drug Class Targeting Midkine
Patent Filed – New Drug Class Targeting Midkine
08/03/22
07:54:13
8 Mar 2022
Holding(s) in Company
Holding(s) in Company
14/02/22
07:00:08
14 Feb 2022
Appointment of Strategic & Scientific Advisor
Appointment of Strategic & Scientific Advisor
08/02/22
11:35:22
8 Feb 2022
Holding(s) in Company
Holding(s) in Company
28/01/22
07:00:09
28 Jan 2022
Holding(s) in Company
Holding(s) in Company
19/01/22
12:56:06
19 Jan 2022
Director/PDMR Shareholding
Director/PDMR Shareholding
19/01/22
08:39:56
19 Jan 2022
Holding(s) in Company
Holding(s) in Company
18/01/22
14:00:32
18 Jan 2022
Price Monitoring Extension
Price Monitoring Extension
18/01/22
11:51:52
18 Jan 2022
Holding(s) in Company
Holding(s) in Company
17/01/22
07:00:08
17 Jan 2022
Holding(s) in Company
Holding(s) in Company
17/01/22
07:00:07
17 Jan 2022
Pre-clinical Update
Pre-clinical Update
10/01/22
08:00:08
10 Jan 2022
Publication of New Research
Publication of New Research
31/12/21
07:00:04
31 Dec 2021
Change of Company Name
Change of Company Name
22/12/21
07:00:07
22 Dec 2021
Holding(s) in Company
Holding(s) in Company
Showing 101–150 of 173 announcements
Previous
1
2
3
4
Next
